Covigenix VAX-002

N/A

Report date: 2024/09/02 11:12:46

Base Information

Drug NameCovigenix VAX-002
Drug Alias NameCOVID-19 plasmid DNA vaccine(Entos Pharmaceuticals)VAX-002ENTVAX002ENTVAX-002
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEntos Pharmaceuticals IncEpiVax IncAegis Life Inc
China Registration ClassN/A

Develop Information

Active CompaniesEpiVax IncEntos Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A